Systematic Financial Management LP Innoviva, Inc. Transaction History

Systematic Financial Management LP

$3.6 Billion
Q2 2025

A detailed history of Systematic Financial Management LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Systematic Financial Management LP holds 2,059,175 shares of INVA stock, worth $40.3 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

2,059,175

Previous 2,071,253 0.58%

Holding current value

$40.3 Million

Previous $37.6 Million 10.16%

% of portfolio

1.15%

Previous 1.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$17.1 - $21.8 $206,533 - $263,300	-12,078 Reduced 0.58%	2,059,175 $41.4 Million
Q1 2025 May 14, 2025	BUY	$17.21 - $18.98 $725,986 - $800,652	42,184 Added 2.08%	2,071,253 $37.6 Million
Q4 2024 Feb 14, 2025	BUY	$17.35 - $20.32 $867,430 - $1.02 Million	49,996 Added 2.53%	2,029,069 $35.2 Million
Q3 2024 Nov 14, 2024	BUY	$16.33 - $20.04 $1.46 Million - $1.8 Million	89,633 Added 4.74%	1,979,073 $38.2 Million
Q2 2024 Aug 15, 2024	SELL	$14.4 - $16.4 $2.65 Million - $3.02 Million	-183,956 Reduced 8.87%	1,889,440 $31 Million
Q1 2024 May 14, 2024	SELL	$14.56 - $16.78 $1.35 Million - $1.55 Million	-92,515 Reduced 4.27%	2,073,396 $31.6 Million
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $610,505 - $806,243	-49,554 Reduced 2.24%	2,165,911 $34.7 Million
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $297,392 - $358,229	-26,110 Reduced 1.16%	2,215,465 $28.2 Million
Q1 2023 May 12, 2023	BUY	$10.73 - $13.6 $3.09 Million - $3.92 Million	288,050 Added 14.75%	2,241,575 $25.2 Million
Q4 2022 Feb 15, 2023	BUY	$11.8 - $13.78 $1.35 Million - $1.58 Million	114,784 Added 6.24%	1,953,525 $25.9 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $4.51 Million - $5.92 Million	388,755 Added 26.81%	1,838,741 $21.3 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $6.8 Million - $9.44 Million	474,712 Added 48.67%	1,449,986 $21.4 Million
Q1 2022 May 11, 2022	BUY	$15.39 - $20.25 $2.12 Million - $2.79 Million	137,801 Added 16.45%	975,274 $18.9 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $1.57 Million - $1.85 Million	98,804 Added 13.38%	837,473 $14.4 Million
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $2.73 Million - $3.6 Million	209,059 Added 39.47%	738,669 $12.3 Million
Q2 2021 Aug 12, 2021	BUY	$11.45 - $13.96 $6.06 Million - $7.39 Million	529,610 New	529,610 $7.1 Million
Q3 2020 Nov 12, 2020	SELL	$10.33 - $14.49 $219,615 - $308,057	-21,260 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$11.49 - $15.26 $118,749 - $157,712	-10,335 Reduced 32.71%	21,260 $297,000
Q1 2020 May 12, 2020	SELL	$8.11 - $15.23 $123,271 - $231,496	-15,200 Reduced 32.48%	31,595 $372,000
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $65,894 - $92,175	-6,410 Reduced 12.05%	46,795 $663,000
Q3 2019 Nov 06, 2019	SELL	$10.05 - $14.55 $92,158 - $133,423	-9,170 Reduced 14.7%	53,205 $561,000
Q2 2019 Jul 26, 2019	SELL	$13.1 - $14.95 $259,642 - $296,309	-19,820 Reduced 24.11%	62,375 $908,000
Q1 2019 May 03, 2019	BUY	$13.69 - $20.06 $155,449 - $227,781	11,355 Added 16.03%	82,195 $1.15 Million
Q4 2018 Feb 13, 2019	SELL	$13.96 - $18.26 $360,935 - $472,112	-25,855 Reduced 26.74%	70,840 $1.24 Million
Q3 2018 Nov 06, 2018	BUY	$13.63 - $15.7 $111,288 - $128,190	8,165 Added 9.22%	96,695 $1.47 Million
Q2 2018 Aug 08, 2018	BUY	$13.44 - $17.59 $44,486 - $58,222	3,310 Added 3.88%	88,530 $1.22 Million
Q1 2018 May 09, 2018	SELL	$13.8 - $16.99 $430,146 - $529,578	-31,170 Reduced 26.78%	85,220 $1.42 Million
Q4 2017 Feb 09, 2018	BUY	$11.73 - $14.75 $106,449 - $133,856	9,075 Added 8.46%	116,390 $1.65 Million
Q3 2017 Nov 08, 2017	BUY	$12.06 - $14.12 $1.29 Million - $1.52 Million	107,315	107,315 $1.52 Million

Others Institutions Holding INVA

# of Institutions

283

Shares Held

80.3M

Call Options Held

10.3K

Put Options Held

161K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.36B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Financial Management LP with notifications on news.

Account

Systematic Financial Management LP Innoviva, Inc. Transaction History